Diabetology

Diabetes mellitus is a rapidly growing global health challenge affecting hundreds of millions of adults and posing significant clinical and economic burdens. India had approximately 101 million people living with diabetes (11.4% prevalence) and 136 million with prediabetes. While 2025-specific national data is currently based on projections, trends suggest the burden continues to rise, especially in urban areas (14.2%–30% prevalence).

Despite decades of research and intervention, prevalence continues to climb—as do its associated complications such as cardiovascular disease, kidney failure, neuropathy, and vision loss. Glycekare is Medley’s focused initiative addressing the growing burden of Type 2 Diabetes Mellitus (T2DM) in India. With a broad range of patient-aligned and clinically relevant medicines, Glycekare provides clinicians with solutions that meet changing patient demands and treatment objectives.

At Medley, Division-Glycekare Offers Diabatic range of product – Vogli range, Dapanova Rang, Corsita Range, Glytrin Range. This demonstrates our dedication to assisting patients in better managing their diabetes and enhancing their quality of life. Our goal is to become a major force in diabetes treatment by offering millions of diabetics in India high-quality, reasonably priced solutions.